Although these metabolites are relatively understudied in AD, existing literature suggests that 2-aminobutyrate may shield cells from oxidative damage by activating glutathione reductase 28 while hypoxanthine induces oxidative stress, mitochondrial abnormality, acetylcholinesterase activity, and neuroinflammation 29–32. The gene discussed is GSR; the disease is Alzheimer disease.